OrPro Therapeutics Presents Data for Lead Compound at Annual North American Cystic Fibrosis Conference

OrPro Therapeutics, Inc., a pre-clinical stage biopharmaceutical company, announced that it will present data on the development of its inhaled treatment for cystic fibrosis (CF) at the 28thAnnual North American Cystic Fibrosis Conference, October 9 – 11 in Atlanta. CF is an inherited … Continued